Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Mitochondrial decay due to oxidative damage is a contributor to brain aging and age-related neurodegenerative diseases, such as Alzheimer's disease (AD) and Parkinson's disease (PD). One type of mitochondrial decay is oxidative modification of key mitochondrial enzymes. Enzyme dysfunction, that is due to poor binding of substrates and coenzymes may be ameliorated by supplementing adequate levels of substrates or coenzyme precursors. Such supplementation with mitochondrial nutrients (mt-nutrients) may be useful to prevent or delay mitochondrial decay, thus prevent or treat AD and PD. In the present review, we survey the literature to identify mt-nutrients that can (1) protect mitochondrial enzymes and/or stimulate enzyme activity by elevating levels of substrates and cofactors; (2) induce phase-2 enzymes to enhance antioxidant defenses; (3) scavenge free radicals and prevent oxidant production in mitochondria, and (4) repair mitochondrial membrane. Then, we discuss the relationships among mt-nutrient deficiency, mitochondrial decay, and cognitive dysfunction, and summarize available evidence suggesting an effect of mt-nutrient supplementation on AD and PD. It appears that greater effects might be obtained by longer-term administration of combinations of mt-nutrients. Thus, optimal doses of combinations of mt-nutrients to delay and repair mitochondrial decay could be a strategy for preventing and treating cognitive dysfunction, including AD and PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free Radicals in Biology and Medicine
Halliwell, B., & Gutteridge, J. M. C. (2015) · doi:10.1093/acprof:oso/9780198717478.001.0001 · Cited by 8,990
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672
Oxidants, antioxidants, and the degenerative diseases of aging.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7915 · Cited by 5,958 · cited 1×
“Mitochondrial decay may be a principal underlying event in aging (Ames et al. 1993, 1995, 2003, Shigenaga et al. 1994, Beckman and Ames 1998, Harman 2002, Roubertoux et al. 2003) and is also associated with in the onset and development of neurodegenerative diseases (Beal 1992, Tritschler et al.…”
BackgroundSelf-citationCommon structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 3×
“Hyperhomocysteinemia has also been shown in a clinical study as an independent risk factor for development of dementia and AD (Seshadri et al. 2002).”
BackgroundMitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283 · cited 3×
“…a defect in complex I of the mitochondrial electron transport chain, i.e. a reduction in the activity of NADH:CoQ reductase (Parker et al. 1989, Schapira et al. 1990, Ebadi et al. 2001); MPTP, which causes a PD-like syndrome in humans and rodents, acts via inhibition of mitochondrial complex I…”
BackgroundOxidative damage and mitochondrial decay in aging.
Shigenaga, M. K., Hagen, T. M., & Ames, B. N. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10771 · Cited by 2,055 · cited 4×
“Mitochondrial decay due to oxidative damage may be an important contributor to aging (Shigenaga et al. 1994, Beckman and Ames 1998, de Grey 1999) and also to PD (Ebadi et al. 2001).”
BackgroundSelf-citationDinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947 · cited 1×
“…activity by elevating levels of substrates and cofactors; that can induce phase-2 enzymes (such as quinone reductase and glutathioneS-transferase) (Dinkova-Kostova et al. 2002, Cao et al. 2003) to enhance cellular antioxidant defenses such as glutathione; than can scavenge free radicals and…”
BackgroundFifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin
Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824 · cited 1×
“Supplementation of nicotinamide to Drosophila resulted in a 15% extension of the mean life span and decreased oxidant generation (Driver and Georgiou 2002) and reduced long-term mortality in humans (Canner et al. 1986).”
BackgroundMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367 · cited 1×
“Increasing evidence suggests that AD and memory loss in AD and other dementia may involve a mitochondrial disorder (Beal 1992, Corral et al. 1994, Mecocci et al. 1994, Albers and Beal 2000, Perry et al. 2000, 2002, Hirai et al. 2001, Cash et al. 2002, Aliev 2003, Roubertoux et al. 2003).”
BackgroundA review of studies on the effect of iron deficiency on cognitive development in children
Grantham-McGregor, S., & Ani, C. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.649s · Cited by 1,293 · cited 1×
“A large literature links iron deficiency and overload to cognitive impairment in humans (Grantham-McGregor and Ani 2001, Beard and Connor 2003, Gordon 2003), including AD (Smith and Perry 1995, Smith et al. 2002) and PD (Berg et al. 2001).”
BackgroundGeneration of reactive oxygen species by the mitochondrial electron transport chain
Liu, Y., Fiskum, G., & Schubert, D. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00744.x · Cited by 1,260 · cited 14×
“LA has been used to treat or prevent diabetic peripheral and cardiac autonomic neuropathy (Ziegler and Gries 1997, Evans and Goldfine 2000), as well as other mitochondrial diseases (reviewed in (Liu et al. 2002a)).”
BackgroundMethodInfluentialRamos-Gomez, M., Kwak, M.-K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., & Kensler, T. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051618798 · Cited by 1,102
Dietary Intake of Antioxidants and Risk of Alzheimer Disease
Engelhart, M. J. (2002) · JAMA · doi:10.1001/jama.287.24.3223 · Cited by 1,080
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037 · cited 1×
“Increasing evidence suggests that AD and memory loss in AD and other dementia may involve a mitochondrial disorder (Beal 1992, Corral et al. 1994, Mecocci et al. 1994, Albers and Beal 2000, Perry et al. 2000, 2002, Hirai et al. 2001, Cash et al. 2002, Aliev 2003, Roubertoux et al. 2003).”
BackgroundBitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205670200 · Cited by 1,002 · cited 1×
“Nicotinamide is also an inhibitor of polyADPribose polymerase and the sir 2 enzymes, which are NAD(þ)-dependent protein deacetylases that play key roles in transcriptional regulation, DNA repair, and life span regulation (Anderson et al. 1999, Bitterman et al. 2002).”
BackgroundEffects of Coenzyme Q10 in Early Parkinson Disease: Evidence of Slowing of the Functional Decline
Shults, C. W. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1541 · Cited by 984 · cited 2×
“Thus, it appears that CoQ slows the progressive deterioration of function in PD (Shults et al. 2002).”
BackgroundTauopathy in Drosophila : Neurodegeneration Without Neurofibrillary Tangles
Wittmann, C. W., Wszolek, M. F., Shulman, J. M., Salvaterra, P. M., Lewis, J., Hutton, M., & Feany, M. B. (2001) · Science · doi:10.1126/science.1062382 · Cited by 939 · cited 8×
“Supplementation of vitamin B6 extended the mean life span of Drosophila by10.”
BackgroundInfluentialAllan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
I RON S TATUS AND N EURAL F UNCTIONING
Beard, J. L., & Connor, J. R. (2003) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.23.020102.075739 · Cited by 669 · cited 1×
“A large literature links iron deficiency and overload to cognitive impairment in humans (Grantham-McGregor and Ani 2001, Beard and Connor 2003, Gordon 2003), including AD (Smith and Perry 1995, Smith et al. 2002) and PD (Berg et al. 2001).”
BackgroundCoskun, P. E., Beal, M. F., & Wallace, D. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403649101 · Cited by 556 · cited 2×
“Defects in mitochondrial oxidative phosphorylation are frequently associated with AD, and both inherited and somatic mtDNA mutations are reported in certain AD cases, such as the recently found somatic mtDNA control-region mutations in AD brain that suppress mitochondrial transcription and replication (Coskun et al. 2…”
BackgroundMicronutrient deficiencies and cognitive functioning
Black, M. M. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.11.3927s · Cited by 438 · cited 2×
“A few reviews have summarized the effects of different nutrients and antioxidants on aging and neurological diseases including PD and AD (Price 2002, Butterfield et al. 2002a, b, Black 2003, Baker and Tarnopolsky 2003, Beal 2003, Marriage et al. 2003, McDaniel et al. 2003).”
BackgroundALZHEIMER'S DISEASE: Genetic Studies and Transgenic Models
Price, D. L., Tanzi, R. E., Borchelt, D. R., & Sisodia, S. S. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.461 · Cited by 406 · cited 1×
“Similarly, in vitro and in vivo AD models (Price et al. 1998, Link 2001) have been developed such as: APP transgenic mice (Masliah et al. 1996), ApoE transgenic mice (Buttini et al. 1999, Raber et al., 2000a) and C elegans (Link et al. 2003), tauopathy Drosophila (Wittmann et al. 2001), and also…”
BackgroundDietary Intake, Dietary Patterns, and Changes With Age: An Epidemiological Perspective
Wakimoto, P., & Block, G. (2001) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/56.suppl_2.65 · Cited by 391 · cited 2×
“Approximately 10% of the U.S. population consumes less than half of the RDA of Vitamin B6 (Wakimoto and Block 2001).”
BackgroundRole of Oxidant Species in Aging
Stadtman, E. R. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365341 · Cited by 368 · cited 1×
“The oxidation of methionine residues of proteins to methionine sulfoxide, which is readily reversed by the action of methionine sulfoxide reductase (Stadtman and Levine 2003, Stadtman et al. 2003), can be considered an antioxidant defense (Stadtman 2004a, b).”
BackgroundBrain iron pathways and their relevance to Parkinson's disease
Berg, D., Gerlach, M., Youdim, M. B. H., Double, K. L., Zecca, L., Riederer, P., & Becker, G. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00608.x · Cited by 362
Tamura, T., Goldenberg, R. L., Hou, J., Johnston, K. E., Cliver, S. P., Ramey, S. L., & Nelson, K. G. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.120688 · Cited by 360 · cited 1×
“Iron deficiency in children is associated with difficulties in performing cognitive tasks and retardation in the development of the CNS (Benton 2001, Tamura et al. 2002).”
BackgroundMarked changes in mitochondrial DNA deletion levels in Alzheimer brains
Corral-Debrinski, M., Horton, T., Lott, M. T., Shoffner, J. M., McKee, A. C., Beal, M. F., Graham, B. H., & Wallace, D. C. (1994) · Genomics · doi:10.1006/geno.1994.1525 · Cited by 309
Rae, C., Digney, A. L., McEwan, S. R., & Bates, T. C. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2003.2492 · Cited by 283 · cited 1×
“A double-blind, placebocontrolled, cross-over trial with 45 young adult, vegetarian subjects showed that oral creatine supplementation (5 g/day for six weeks) had a significant positive effect on both working memory and intelligence, both tasks that require speed of processing (Rae et al. 2003).”
BackgroundBeal, M. F., Matthews, R. T., Tieleman, A., & Shults, C. W. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01192-x · Cited by 256 · cited 2×
“CoQ attenuates MPTP-induced generation of oxidants, and attenuates MPTP-induced dopamine depletion in the striatum (Beal et al. 1998, Ebadi et al. 2001).”
BackgroundZinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts
Ho, E., Courtemanche, C., & Ames, B. N. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.8.2543 · Cited by 252 · cited 4×
“…or the cellpermeant glutathione precursor, N-acetyl-L-cysteine, or vitamin E prevents generation of oxidants and neurotoxicity induced by folate deficiency and amyloid-beta, suggesting that folate levels modulate the extent of amyloid-beta and homocysteine neurotoxicity in AD (Ho et al. 2003b).”
BackgroundInfluentialApolipoprotein E and cognitive performance
Raber, J., Wong, D., Yu, G.-Q., Buttini, M., Mahley, R. W., Pitas, R. E., & Mucke, L. (2000) · Nature · doi:10.1038/35006165 · Cited by 237
Bioenergetic approaches for neuroprotection in Parkinson's disease
Beal, M. F. (2003) · Annals of Neurology · doi:10.1002/ana.10479 · Cited by 236 · cited 15×
“Creatine increases creatine/phosphocreatine and inhibits the opening of the mitochondrial permeability transition pore (Beal 2003).”
BackgroundMethodInfluentialInhibition of NADH-Linked Mitochondrial Respiration by 4-Hydroxy-2-nonenal
Humphries, K. M., Yoo, Y., & Szweda, L. I. (1998) · Biochemistry · doi:10.1021/bi971958i · Cited by 231
The Importance of Proteins in Defense Against Oxidation
Bourdon, E., & Blache, D. (2001) · Antioxidants & Redox Signaling · doi:10.1089/152308601300185241 · Cited by 220 · cited 1×
“Oxidants and oxidative products are known to modify proteins, alter enzyme activity and affect cellular functions, receptor-mediated processes, and protein turnover (Gutteridge 1981, Fu et al. 1995, Morin et al. 1998, Stadtman and Levine 2000, Bourdon and Blache 2001, Stadtman and Levine 2003).”
BackgroundMontgomery, S. A., Thal, L. J., & Amrein, R. (2003) · International Clinical Psychopharmacology · doi:10.1097/00004850-200303000-00001 · Cited by 209
Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline
Morris, M. C. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.025858 · Cited by 196 · cited 2×
“Niacin intake from foods is found to be inversely associated with AD and higher food intake of niacin was associated with a slower annual rate of cognitive decline suggesting that dietary niacin may protect against AD and age related cognitive decline (Morris et al. 2004).”
BackgroundAlpha-lipoic acid as a new treatment option for Azheimer type dementia
Hager, K., Marahrens, A., Kenklies, M., Riederer, P., & Münch, G. (2001) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(01)00104-2 · Cited by 188
Buttini, M., Yu, G.-Q., Shockley, K., Huang, Y., Jones, B., Masliah, E., Mallory, M., Yeo, T., Longo, F. M., & Mucke, L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10539.2002 · Cited by 183 · cited 1×
“…(Price et al. 1998, Link 2001) have been developed such as: APP transgenic mice (Masliah et al. 1996), ApoE transgenic mice (Buttini et al. 1999, Raber et al., 2000a) and C elegans (Link et al. 2003), tauopathy Drosophila (Wittmann et al. 2001), and also APP þ ApoE mice (Buttini et al. 2002).”
BackgroundHomocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence
Bjørke Monsen, A. L., & Ueland, P. M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.1.7 · Cited by 144
Acetyl-l-carnitine for dementia
Hudson, S. A., & Tabet, N. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003158 · Cited by 86
Oxidation of Aβ and Plaque Biogenesis in Alzheimer's Disease and Down Syndrome
Head, E., Garzon-Rodriguez, W., Johnson, J. K., Lott, I. T., Cotman, C. W., & Glabe, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0431 · Cited by 75
Acetyl-levo-carnitine protects against MPTP-induced parkinsonism in primates
Bodis-Wollner, I., Chung, E., Ghilardi, M. F., Glover, A., Onofrj, M., Pasik, P., & Samson, Y. (1991) · Journal of Neural Transmission - Parkinson's Disease and Dementia Section · doi:10.1007/bf02251137 · Cited by 51 · cited 2×
“ALCAR was proposed as a therapeutic agent for protecting against MPTP-induced toxicity in neuroblastoma cells (Mazzio et al. 2003) and in monkeys (Bodis-Wollner et al. 1991).”
BackgroundNo evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia
Rainer, M., Kraxberger, E., Haushofer, M., Mucke, H. A. M., & Jellinger, K. A. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070011 · Cited by 46 · cited 8×
“NADH is a substrate for mitochondrial complex I. NADH and NADPH may act as endogenous antioxidants (Kirsch and De Groot 2001).”
BackgroundInfluential
Cited by
The role of mitochondria in reactive oxygen species metabolism and signaling
Starkov, A. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.015 · Cited by 846
Flora, S. J. S. (2009) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.2.4.9112 · Cited by 616
Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity
Calabrese, V., Cornelius, C., Dinkova-Kostova, A. T., Iavicoli, I., Di Paola, R., Koverech, A., Cuzzocrea, S., Rizzarelli, E., & Calabrese, E. J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.002 · Cited by 420
Cui, X., Zuo, P., Zhang, Q., Li, X., Hu, Y., Long, J., Packer, L., & Liu, J. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20845 · Cited by 408
Self-citationWang, X., Su, B., Fujioka, H., & Zhu, X. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071208 · Cited by 341
Metadata
- Authors
- Liu, J., & Ames, B. N.
- Venue
- Nutritional Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2005-04
- Volume
- 8
- Issue
- 2
- Pages
- 67-89
- ISSN
- 1028-415X (ISSN-L)
- 1476-8305
- OpenAlex
- W2093426698
- Cited by
- 137
- References
- 44
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.